Acadia Pharmaceuticals Inc. (ACAD)
BMV
Closed
Aug 21, 2026
Day's Range
453.7552 wk Range
362.00Overview - ACAD - Acadia Pharmaceuticals Inc.
Key Statistics
Valuation
Enterprise Value
1.30T
P/E (Trailing)
‪13.49‬
PEG Ratio
‪1.07‬
Price / Sales (TTM)
‪77.17‬
Price / Book
‪3.97‬
EV / EBITDA
‪785.64‬
Profitability
Gross Margin
‪90.80%‬
Profit Margin
‪33.41%‬
Operating Margin
‪12.28%‬
Return on Assets
‪3.63%‬
Return on Equity
‪35.74%‬
Ownership
Shares Outstanding
172.13M
Float
128.35M
Held by Insiders
‪0.32%‬
Held by Institutions
‪99.76%‬
Price stats
Beta
‪0.84‬
50-Day Avg
‪424.78‬
200-Day Avg
‪425.90‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ACAD - Acadia Pharmaceuticals Inc.
Peers - ACAD - Acadia Pharmaceuticals Inc.
Peer Comparison
Compared with companies in Biotechnology listed on BMV.
- ACADBMVAcadia Pharmaceuticals Inc.77.69BMarket Cap-12.18%52-week change13.49P/E (Trailing)‪33.41%‬Profit Margin
- ARGXNBMVargenx SE American Depositary Receipt931.67BMarket Cap+4.58%52-week change33.44P/E (Trailing)‪32.26%‬Profit Margin
- ALNYBMVAlnylam Pharmaceuticals Inc742.50BMarket Cap-54.26%52-week change57.14P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNBMVBioNTech SE492.36BMarket Cap+4.53%52-week change1.65P/E (Trailing)‪-63.63%‬Profit Margin
- BMRNBMVBioMarin Pharmaceutical Inc.218.20BMarket Cap+4.43%52-week change178.64P/E (Trailing)‪2.14%‬Profit Margin
- AGIOBMVAgios Pharmaceuticals Inc.72.95BMarket Cap+0.00%52-week change5.17P/E (Trailing)‪88.25%‬Profit Margin
- ARWRBMVArrowhead Pharmaceuticals Inc.64.20BMarket Cap+0.00%52-week change-45455.00P/E (Trailing)‪-47.79%‬Profit Margin
Profile Summary - ACAD - Acadia Pharmaceuticals Inc.
About
Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on discovering and commercializing medicines for central nervous system and neurological disorders. The company's commercial portfolio includes NUPLAZID, the first and only FDA-approved treatment for hallucinations and delusions associated with…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
